Colgate-Palmolive (NYSE:CL) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Colgate-Palmolive (NYSE:CL – Free Report) from a hold rating to a buy rating in a research note published on Monday. Several other equities research analysts have also weighed in on the company. Barclays lowered their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the […]

Leave a Reply

Your email address will not be published.

Previous post MEG Energy (TSE:MEG) Hits New 52-Week Low Following Analyst Downgrade
Next post Immunovant (NASDAQ:IMVT) Coverage Initiated at Jefferies Financial Group